ABSTRACT Trans-lPtCl(N,N-dimethylamine) 
INTRODUCTION
Cisplatin [cis-diammmedichloroplatinum (II), cis-DDP] is one of the most widely used drugs in the treatment of cancer. It shows remarkable activity alone or in combination with other drugs in the treatment of several tumors, including those of the lung, ovary, testes and bladder [1, 2] . The success of cis-DDP as an antiturnor drug has been attributed to different factors, including penetration of the cellular membrane, accumulation in the tumor cell. and efficiency in coordinating with chromosomal DNA [3, 4] . The extent of DNA lesions induced by cis-DDP in the cell nuclei and the cell killing potential of the drug is believed to depend on the cellular level of reactive platinum species and the persistence of platinum within the cells [5, 6] .
Despite the success of cis-DDP against certain types of cancer, the patients treated with the drug suffer from severe side effects including nephrotoxicity, nausea and vomiting, myelosuppression and ototoxicity [2, 3] . Moreover, quite often tumors become resistant to cisplatin [7] . The cis-DDP resistance may take place at various levels, including cellular accumulation, interaction with glutathione (GSH) and/or metallothioneins, DNA repair and defective apoptotic program [8] .
Although transplatin or trans-DDP (the stereoisomer of cisplatin) is clinically inactive, several classes of trans-platinum complexes show antitumor activity and some of them are able to circumvent cisplatin resistance [9] . Trans-[PtCl2(N,N-dimethylamine)(isopropylamine)] ( Figure 1 ) is a novel trans-platinum(II) complex with mixed aliphatic amine ligands which show cytotoxic activity in tumor cell lines sensitive and resistant to cisplatin [ 10] . Moreover, trans.
[PtC12(N,N-dimethylamine)(isopropylamine)] induces tumor cell death through apoptosis [ 11 ] .
The A2780cisR human ovarian tumor cell line may be considered a model to study cisplatinresistance because it exhibits acquired resistance to cis-DDP from a combination of decreased uptake, enhanced DNA repair/tolerance and elevated GSH levels [ 1.2, 13 Pt, in order to obtain a correct deconvolution of profiles associated with the general spectrum. The Pt line was used for Pt quantification. The analytical sensitivity of the TXRF measurements was 0.3 to 22.4 ng Pt in a solution volume of 100 tl, with repeatability between 2 and 8% (n 3). lntracellular GSH content, lntracellular GSH levels were determined, in A2780 and A2780cisR cells growing as specified for the Cytotoxicity tests. Approximately 5 xl05 cells/ml were seeded into P100 plates, and, after overnight incubation, cells were washed twice with ice-cold PBS. Cellular GSH was then extracted using 2 ml of ice-cold 0.6% sulfosalicilic acid followed by a 10 min incubation at 4C. Total GSH content in the extract was then determined according to the method of Griffiths [ 18] . Protein quantification was carded out after solubilization in 2 ml of sodium hydroxide 1M using the Lowry assay [19] . The We also quantified the levels of platinum binding to DNA when the A2780cisR cells were pre-exposed to L-BSO before treatment with the platinum drugs. Figure 5 shows that under these conditions 
